Repro Med Systems Inc(KRMD) 因证券欺诈案已经于近日被投资者诉至法院。在目前的诉讼中投资者指控该公司在2020年8月4日至2021年1月25日期间就公司的业务和运营状况及发展前景进行虚假陈述,未向投资者披露以下重大不利...查看全文
$Repro Med Systems(KRMD)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001161697-20-000250 Act: 33 Size: 299 KB 网页链接
$Repro Med Systems(KRMD)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001161697-20-000247 Act: 34 Size: 5 MB 网页链接
$Repro Med Systems(KRMD)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001161697-20-000248 Act: 33 Size: 301 KB 网页链接
$Repro Med Systems(KRMD)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001161697-20-000226 Act: 34 Size: 35 KB 网页链接
$Repro Med Systems(KRMD)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-001224 Act: 33 Size: 1 KB 网页链接
$Repro Med Systems(KRMD)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001161697-20-000208 Act: 33 Size: 940 KB 网页链接
$Repro Med Systems(KRMD)$ 8-K Current report, item 8.01 Accession Number: 0001161697-20-000206 Act: 34 Size: 9 KB 网页链接
$Repro Med Systems(KRMD)$ 内部交易: 2020-05-09,CFO,Fisher Karen ,期权,535000普通股, $0.60
$Repro Med Systems(KRMD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001161697-20-000201 Size: 12 KB 网页链接
$Repro Med Systems(KRMD)$ 3/A [Amend] Initial statement of beneficial ownership of securities Accession Number: 0001161697-20-000194 Size: 11 KB 网页链接